An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. (Record no. 12063738)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02130 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514042041.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200211s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0923-7534 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1093/annonc/mdf253 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Mead, G M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20021121 |
245 00 - TITLE STATEMENT | |
Title | An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
Date of publication, distribution, etc. | Aug 2002 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1264-74 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Burkitt Lymphoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclophosphamide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytarabine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Evaluation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Etoposide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ifosfamide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | L-Lactate Dehydrogenase |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Methotrexate |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United Kingdom |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vincristine |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sydes, M R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walewski, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grigg, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hatton, C S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pescosta, N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guarnaccia, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lewis, M S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | McKendrick, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stenning, S P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wright, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Norbert, P |
773 0# - HOST ITEM ENTRY | |
Title | Annals of oncology : official journal of the European Society for Medical Oncology |
Related parts | vol. 13 |
-- | no. 8 |
-- | p. 1264-74 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdf253">https://doi.org/10.1093/annonc/mdf253</a> |
Public note | Available from publisher's website |
No items available.